Like several housebuilders reporting this week, Redrow PLC (LSE:RDW), is likely to report continued softness in reservations as higher interest rates weigh on the housing market.
Analysts and investors will be keen to hear updates on recent sales rates and what is happening to selling prices and costs … read the preview.
In macro news, the UK GDP numbers are expected to show the economy slowed sharply at the start of the second half, given the combined pressures from higher rates as well as higher prices.
In the first quarter, the economy grew 0.1% and then 0.2% in the second, with the third quarter expected to see stagnation or even a modest contraction of -0.1%.
A day after, Saturday will see news about one of what investors are treating as one of the most significant drugs of all time: Novo Nordisk's (NYSE:NVO) weight loss injection Wegovy/Ozempic.
At the American Heart Association (AHA) conference in Philadelphia, Novo will present full details of the SELECT study, for which preliminary data sent its shares soaring on predictions of annual sales around $70 billion, with a potential "paradigm shift" in the way obesity is treated and knock-on effects on demand for other medical treatments, health services and even food ...read the preview.
Others due to report:
Trading updates: Allianz Technology Trust PLC (LSE:ATT) (Allianz Technology Trust PLC (LSE:ATT))
Interims: Castings PLC (LSE:CGS) (Castings PLC (LSE:CGS)), Wheaton Precious Metals Corporation
AGMs: DFS Furniture PLC (LSE:DFS), Gallford Try Holdings PLC, Minoan Group PLC (AIM:MIN), Quartix Technologies PLC (AIM:QTX)
Economic announcements: Balance of Trade (UK), Gross Domestic Product (UK), Index of Services (UK), Industrial Production (UK), Manufacturing Production (UK), University of Michigan Confidence (Preliminary) (US)